Researchers engineered lipid nanoparticles to deliver a full CFTR gene into human airway cells, restoring near-normal ...

Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.

Researchers developed a simulation showing how lipid nanoparticles release mRNA in acidic endosomes. The study reveals how ...

Moderna (NASDAQ:MRNA) just hit a legal speed bump after a federal judge in Delaware knocked out 2 major defenses in its patent battle with Arbutus Biopharma (NASDAQ:ABUS) over mRNA vaccine technology.

Researchers at the Icahn School of Medicine at Mount Sinai say they have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a ...

Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...

In early February 2026, the U.S. District Court for the District of Delaware denied Moderna’s bid for summary judgment in a ...

Northwestern University has filed a patent infringement lawsuit against Moderna, Inc. (NASDAQ:MRNA), alleging the pharmaceutical company used the university’s lipid nanoparticle (LNP) technology ...

Christchurch nanotechnology company Izon Science has announced a new high-precision measurement system aimed at the rapidly expanding global markets for mRNA vaccines and advanced medical therapies.

Malvern Panalytical’s recent peer-reviewed publication, Tailoring Lipid Nanoparticle Dimensions Through Manufacturing Processes, published in RSC Pharmaceutics, features both the NanoSight Pro ...